NasdaqCM - Delayed Quote USD

Protagenic Therapeutics, Inc. (PTIXW)

0.0450
-0.0050
(-10.00%)
At close: June 12 at 4:00:00 PM EDT
Loading Chart for PTIXW
  • Previous Close 0.0500
  • Open 0.0450
  • Bid --
  • Ask --
  • Day's Range 0.0450 - 0.0450
  • 52 Week Range 0.0450 - 0.0450
  • Volume 490
  • Avg. Volume --
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 0.38
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company's lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.

www.protagenic.com

1

Full Time Employees

--

Fiscal Year Ends

Recent News: PTIXW

View More

Compare To: PTIXW

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PTIXW

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -189.60%

  • Return on Equity (ttm)

    -512.79%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -5.24M

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    872.96k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -1.71M

Research Analysis: PTIXW

View More

Company Insights: PTIXW

Research Reports: PTIXW

View More

People Also Watch